Made up of world-renowned scientists, the Committee’s task is to ensure that Telethon funds are assigned to the most promising projects from among those submitted in response to our calls for proposals. It also monitors the work of our Institutes.

Our Scientific Committee places excellence at the heart of every evaluation; this is the principle on which its members base their choice of which projects are worthy of funding, never overlooking the fact that those same projects must be relevant to patients’ needs and contribute towards finding a cure. Our Scientific Committee members are from all over the world and remain in office for four years. Only a few are from Italy, so as to avoid conflicts of interest.   

2632 funded projects and activities
1612 funded researchers

The members of the Scientific Committee 

  • Yvan Arsenijevic, Hôpital Ophtalmique Jules Gonin (Lausanne, Switzerland)
  • Victoria P. Belancio, Tulane University (New Orleans, LA - USA)
  • Robert M. Brosh, National Institute on Aging (Baltimore, MD – USA)
  • Patrick Brundin, Center for Neurodegenerative Science, Van Andel Institute (Grand Rapids, MI –USA)
  • Judith Campisi, Buck Institute for Research on Aging (Novato, CA – USA)
  • Jeffrey S. Chamberlain, University of Washington (Seattle, WA – USA)
  • Jeffrey Dilworth, Ottawa Hospital Research Institute (Ottawa, Canada) – Vice Chairperson
  • Daniel Garry, University of Minnesota (Minneapolis, - USA)
  • Alfred L. George, Feinberg School of Medicine, Northwestern University (Chicago, IL – USA)
  • Gregory G. Germino, National Institutes of Health, Kidney Disease Branch/National Institute of Diabetes and Digestive and Kidney Disease (Bethesda, MD – USA)
  • Markus Glatzel, University Medical Center Hamburg-Eppendorf, UKE (Hamburg, Germany)
  • Åsa Gustafsson, UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences (San Diego, La Jolla, CA - USA)
  • Simon Heales, University College London – UCL (UK)
  • Lynn Jorde, University of Utah (Salt Lake City, UT –USA)
  • Nicholas Katsanis, Northwestern University Feinberg School of Medicine (Chicago, IL – USA)
  • Albert R. La Spada, Duke University School of Medicine (Durham, NC  -USA)
  • Holger Lerche, University of Tübingen (Tübingen, Germany)
  • Fransiska Malfait, Center for Medical Genetics, Ghent Universit (Ghent, Belgium)
  • Punam Malik, University of Cincinnati (Cincinnati, OH – USA)
  • Jeffrey Molkentin, University of Cincinnati (Cincinnati, OH – USA)
  • Geert Mortier, Antwerp University Hospital (Antwerp, Belgium)
  • Michael P. Murphy, University of Cambridge, (Cambridge, UK)
  • Nael Nadif Kasri, Radboud University Nijmegen (Nijmegen, The Netherlands)
  • Kanneboyina Nagaraju, Department of Pharmaceutical Sciences, Binghamton University (Binghamton, NY - USA)
  • Bradley B.  Olwin, University of Colorado (Boulder, CO - USA)
  • Harry Orr, University of Minnesota (Minneapolis, MN – USA)
  • Francesc Palau, Institute of Rare and Genetic Diseases (Barcelona, Spain)
  • Massimo Pandolfo, Erasme Hospital (Brussels, Belgium)
  • Ambra Pozzi, Vanderbilt University (Nashville, TN - USA)
  • Thomas A. Rando, Stanford University School of Medicine (Stanford, CA – USA)
  • Laura Ranum, University of Florida (Gainesville, FL – USA)
  • Paul Robbins, University of Minnesota Medical School (Minneapolis, MN –USA).
  • Michael Talkowski, Broad Institute of MIT and Harvard (Cambridge, MA - USA)
  • Naomi Taylor, Institute of Molecular Genetics of Montpellier (Montpellier, France) and National Human Genome Research Institute, NIH (Bethesda, MD – USA) Chairperson
  • Raul Urrutia, Medical College of Wisconsin (Milwaukee, WI - USA)
  • Charles Venditti, National Human Genome Research Institute, NIH (Bethesda, MD – USA)
  • Ora A. Weisz, University of Pittsburgh School of Medicine(Pittsburgh, PA – USA)

Il tuo browser non è più supportato da Microsoft, esegui l'upgrade a Microsoft Edge per visualizzare il sito.